Half Year 2019 Futura Medical PLC Earnings Call Transcript
Good morning, everybody. Thank you for joining us at Futura Medical Interim Results for the period ending 30th of June 2019. I'm Angela Hildreth. I'm the Finance Director and COO. I'm joined by James Barder, who's our CEO; and Ken James, who is our Head of R&D.
Thank you, Angela.
Turning to Slide 4. A little bit of -- sort of a bit of our corporate overview.
Fundamentals for the company. We're listed on AIM. And we describe ourselves as a virtual organization with 15 staff and with low overheads. We have 2 -- actually, 3 service offices in Guildford. And we have a lot of our infrastructures outsourced with over 30 consultants.
Our key asset is our clinically proven transdermal science known as DermaSys, where we look to drive drugs through the skin. Ken will talk about that a little bit later during his presentation.
Our real track record is really around
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
